Laekna (HKG:2105) said it granted 15.3 million restricted share units to three executive directors and employees, according to a Friday filing with the Hong Kong bourse.

The drug company's shares gained nearly 5% in morning trade Monday.

Of the total, 7.7 million RSUs were earmarked for employees, while an additional 2.6 million RSUs were granted to Lu Chris Xiangyang, Gu Xiang-Ju Justin, and Xie Ling.